Анна Петровна Соколенко
Institute of Oncology NN Petrov · 225 works · 3,274 citations · h-index 29
Top works
- Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 / 2 (CIMBA)
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
- Novel ALK fusion partners in lung cancer
- High frequency of BRCA1 5382insC mutation in Russian breast cancer patients
- Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia
- High response rates to neoadjuvant platinum-based therapy in ovarian cancer patients carrying germ-line BRCA mutation
- Molecular Diagnostics in Clinical Oncology
- NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia
- Family History, Genetic Testing, and Clinical Risk Prediction: Pooled Analysis of CHEK2*1100delC in 1,828 Bilateral Breast Cancers and 7,030 Controls
- High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia
- Multigene sequencing reveals heterogeneity of NLRP12-related autoinflammatory disorders
- CHEK2 1100delC mutation is frequent among Russian breast cancer patients
- CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors
- High sensitivity of BRCA1-associated tumors to cisplatin monotherapy: report of two cases
- Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations
- PALB2 mutations in German and Russian patients with bilateral breast cancer
- Evidence for clinical efficacy of mitomycin C in heavily pretreated ovarian cancer patients carrying germ-line BRCA1 mutation
- Hereditary cancer syndromes
- High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients
- Complete Clinical Response of BRAF-Mutated Cholangiocarcinoma to Vemurafenib, Panitumumab, and Irinotecan